Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2026

Feb 19, 2026

30561_dirs_2026-02-18_3a0a14c7-9ec9-4a14-b2d3-a091c7427d75.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2026-02-13

Reporting Person: Oliver Bob (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-13 Common Stock M 9088 $19.28 Acquired 51370 Direct
2026-02-13 Common Stock S 9088 $43.61 Disposed 42282 Direct
2026-02-13 Common Stock S 21162 $43.90 Disposed 21120 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-13 Option (right to buy) $19.28 M 9088 Disposed 2030-05-30 Common Stock (9088) Direct

Footnotes

F1: Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic
equivalent of one share of Common Stock.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security
holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnote 2 to this Form 4.

F3: The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.